Jon Hamrick, Therigy’s Executive Vice President, Biotech & Specialty Services, will be a speaker at CBI’s Speed to Therapy Strategy Summit, a high-level conference aimed at key players in the pharmaceutical industry.
The theme of the conference is Optimize Stakeholder Collaboration and Shorten Time to Fill. Held in Philadelphia, it provides a forum in which colleagues across the industry can collaborate to devise best practices and develop effective solutions to shorten patient wait time and increase speed to therapy.
Hamrick along with co-presenters Dan Duffy, Chief Business Development Officer of Biologics Inc., and Jacquelyn Hall, Director, Client Engagement at UBC ,will discuss Specialty Therapy Access — Integrate Support and Specialty Pharmacy Services to Optimize Patient and Provider Experience. The session is set for 2 p.m. Tuesday, Aug. 11, the first day of the conference.
Therigy also will be exhibiting at the two-day event.
CBI is a leader in conferences for the pharmaceutical industry.
Therigy is the trusted source for innovative, best-in-class software and expert consulting services to the specialty pharmaceutical market. Clients leverage Therigy’s solutions, data, and insights to achieve clinical and economic success by aligning strategy, technology, and people.